MediciNova Accounts Payable from 2010 to 2024
| MNOV Stock | USD 2.00 0.05 2.56% |
Accounts Payable | First Reported 2004-09-30 | Previous Quarter 667.7 K | Current Value 708.2 M | Quarterly Volatility 78.6 M |
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.9 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
MediciNova | Accounts Payable |
Latest MediciNova's Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of MediciNova over the last few years. An accounting item on the balance sheet that represents MediciNova obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of MediciNova are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. MediciNova's Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.
| Accounts Payable | 10 Years Trend |
|
Accounts Payable |
| Timeline |
MediciNova Accounts Payable Regression Statistics
| Arithmetic Mean | 555,505 | |
| Geometric Mean | 434,399 | |
| Coefficient Of Variation | 63.91 | |
| Mean Deviation | 248,764 | |
| Median | 461,970 | |
| Standard Deviation | 355,023 | |
| Sample Variance | 126B | |
| Range | 1.5M | |
| R-Value | 0.31 | |
| Mean Square Error | 122.8B | |
| R-Squared | 0.1 | |
| Significance | 0.26 | |
| Slope | 24,554 | |
| Total Sum of Squares | 1.8T |
MediciNova Accounts Payable History
About MediciNova Financial Statements
MediciNova investors use historical fundamental indicators, such as MediciNova's Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MediciNova. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Accounts Payable | 1 M | 722.3 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.